Transportation and Logistics Readiness Service
ID: 75A50325R00001Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSEASPR ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSEWashington, DC, 20201, USA

NAICS

Specialized Freight (except Used Goods) Trucking, Long-Distance (484230)

PSC

TRANSPORTATION/TRAVEL/RELOCATION- TRANSPORTATION: MOTOR FREIGHT (V112)

Original Source

https://sam.gov/opp/dd767932c3274c8b93940aec847ffb83/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response, is seeking proposals for Transportation and Logistics Readiness Services related to the Strategic National Stockpile (SNS). This procurement involves a Firm Fixed Price contract for a duration of 48 months, which includes a base year and three one-year options, focusing on ultra-cold chain container services to transport pharmaceuticals and medical supplies at temperatures between -70°C and -80°C. The services are critical for ensuring the integrity and readiness of essential medical supplies during public health emergencies, with strict requirements for temperature monitoring, emergency response, and compliance with transportation regulations. Proposals must be submitted electronically by November 19, 2024, and interested parties can contact Lawrence McCoy or Mattie Washington via email for further information.

    Point(s) of Contact
    Lawrence McCoy
    Lawrence.Mccoy@hhs.gov
    Mattie Washington
    Mattie.Washington@hhs.gov
    Files
    Title
    Posted
    Cold Chain Combined Synopsis Solicitation 11.4.2024.pdf
    The document presents a combined synopsis/solicitation (RFP 75A50325R00001) from the U.S. Department of Health and Human Services for Transportation and Logistics Readiness Services related to the Strategic National Stockpile (SNS). It seeks proposals for a Firm Fixed Price contract for a period of 48 months, including a base year and three one-year options, focusing on ultra-cold chain container services to transport pharmaceuticals and medical supplies at -70°C to -80°C. The RFP emphasizes strict requirements for transportation, including continuous temperature monitoring, emergency response capabilities, and compliance with all relevant transportation regulations. Proposals must include technical and pricing details, submitted electronically by November 19, 2024. The document outlines detailed expectations for deliverables including plans for logistics, temperature logs, and delivery confirmations. Key additional requirements include comprehensive communication throughout the transport process, contingency plans for equipment failures, and rigorous vetting for contracted carriers. The anticipated objective is to ensure the readiness and integrity of critical medical supplies during emergencies, enhancing the SNS’s capacity to respond to public health crises.
    Lifecycle
    Title
    Type
    Transportation and Logistics Readiness Service
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Procurement of storage and stability services to maintain BARDA’s supply of Live Attenuated Influenza Virus Master and Working Seed Lots
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS), specifically the Biomedical Advanced Research and Development Authority (BARDA), is seeking to procure storage and stability services for maintaining its supply of Live Attenuated Influenza Virus Master and Working Seed Lots. The procurement aims to ensure that these seed lots remain within specification for use in clinical trials or commercial drug production, which is critical for pandemic preparedness. The contract will be awarded on a sole source basis to MedImmune, LLC, which has been performing these services under a previous indefinite-delivery, indefinite-quantity contract since 2016. Interested parties may submit capability statements or quotations for consideration, and inquiries can be directed to Deitra Williams at deitra.williams@hhs.gov or Corneilus Stephens at corneilus.stephens@hhs.gov.
    RFI-Transportable Patient Biocontainment, Isolation, and Quarantine Systems
    Active
    Dept Of Defense
    The U.S. Department of Defense seeks innovative solutions for its Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Protection (JPM CBRN Protection) program. The requirement is for transportable biocontainment, isolation, and quarantine (BIQ) systems, or components thereof, to be used across various platforms such as ships, aircraft, wheeled vehicles, and field deployable systems. These systems are crucial in preventing the spread of biological threats and addressing public health emergencies. Modularity, scalability, and compatibility with existing healthcare infrastructure are key attributes the government seeks, along with strict adherence to safety and quality standards. The focus is on finding deployable and sustainable solutions to contain hazardous pathogens, with the potential for multiple system applications across different platforms. An upcoming Innovation Day on October 9th, 2024, will provide an opportunity for interested parties to discuss their technologies and gain a deeper understanding of the government's requirements. Per the request, responses must be submitted via email to Brian Liska at brian.liska@usmc.mil by November 8th, 2024, at 5:00 p.m. EST. The contact email is brian.liska@usmc.mil, and further details can be found on the SAM.gov website.
    HHS ONE PROFESSIONAL SERVICES SOLUTION (HOPSS)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS) is seeking qualified small business sources for the HHS One Professional Services Solution (HOPSS) to support its mission of enhancing the health and well-being of Americans. This procurement aims to identify small businesses capable of providing professional services in two primary task areas: Science, Technology, Engineering, and Math (STEM) services, and business and operational services to support STEM activities, aligning with HHS's strategic goals for 2022-2026. The contract will facilitate access to essential services that advance healthcare, public health, and social equity, with a focus on emerging research and technologies. Interested organizations must submit their capability statements by November 26, 2024, to Kyle Miller at kyle.miller2@nih.gov, and a Market Research Industry Day is scheduled for November 19, 2024, to discuss the requirements further.
    Non-Human Primate (NHP) Transportation Services, WRAIR
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA) and the Army Medical Research Acquisition Activity, is seeking qualified contractors to provide transportation services for 18 Indian-origin rhesus macaques from the Walter Reed Army Institute of Research (WRAIR) to the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand. The procurement requires compliance with various regulatory standards, including CITES and the Animal Welfare Act, necessitating the contractor to manage both ground and international air travel while ensuring health and safety protocols are strictly followed. This transportation service is critical for ongoing research and medical studies involving non-human primates, emphasizing the importance of adhering to health regulations and obtaining necessary permits. Interested parties must submit their capabilities and a cover page via email by November 22, 2024, to Nathaniel Reus at Nathaniel.a.reus.civ@health.mil, with further details outlined in the attached Sources Sought document.
    Non-Reinforced Heat Reflective Shell – Hypothermia Prevention
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for the MD-2409-56 Non-Reinforced Heat Reflective Shell, aimed at hypothermia prevention in non-hospital settings. This initiative seeks to identify and evaluate products designed to envelop patients suffering from hypothermia, with specifications including materials such as Bi-axially-oriented polyethylene terephthalate (BoPET) and options for both active and passive heat sources. The QSL will facilitate the procurement of these critical medical supplies, which must comply with Trade Agreements Act (TAA) regulations and be manufactured in compliant countries. Interested vendors should ensure they have an active Distribution and Pricing Agreement (DAPA) and are registered in the System for Award Management (SAM) to participate. For further details, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil, and should monitor the SAM.gov website for the forthcoming QSL Announcement expected around December 12, 2024.
    Rapid Pandemic Influenza and Emergency Infectious Disease Vaccine Development and Response Capability
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (BARDA), is seeking proposals for the "Rapid Pandemic Influenza and Emergency Infectious Disease Vaccine Development and Response Capability" through a Special Notice. The objective of this procurement is to establish a long-term partnership focused on developing a flexible and rapid response capability for vaccine development against pandemic influenza and other priority pathogens, initially emphasizing influenza mRNA vaccine development. This initiative is critical for enhancing the nation's preparedness and response to emerging infectious diseases, ensuring readiness to pivot quickly in the face of public health threats. Interested parties can access the full Request for Project Proposals and additional consortium information at www.rrpv.org, and inquiries can be directed to Rebecca Harmon at rebecca.harmon@ati.org.
    NIAID PROFESSIONAL, SCIENTIFIC AND TECHNICAL SUPPORT SERVICES (PSTSS)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) NIAID, is seeking proposals for Professional, Scientific, and Technical Support Services (PSTSS) to assist with various research initiatives, including basic, translational, and clinical research, as well as vaccine development and laboratory research across multiple biosafety levels. The procurement aims to secure specialized expertise to enhance the effectiveness of ongoing and future research efforts critical to public health. Proposals are due by December 16, 2024, with the contract period set to commence on June 1, 2025, and potentially extend to November 30, 2030, with a total funding cap of $3 billion across all awarded contracts. Interested parties can reach out to Rosemary Gomes at Rosemary.Gomes@nih.gov or Kristel Turansky at Kristel.Turansky@nih.gov for further information.
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.
    RRPV Solicitation Summary: NextGen Oral Formulation Vaccines for COVID-19
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals for the "NextGen Oral Formulation Vaccines for COVID-19" under the Rapid Response Partnership Vehicle (RRPV) Consortium. The objective of this initiative is to advance oral vaccine platforms and technologies into a proof-of-concept Phase 1 clinical trial, enhancing understanding of their potential and improving COVID-19 solutions to bolster preparedness against future health security threats. This effort is critical in the ongoing response to the COVID-19 pandemic and aims to develop innovative vaccine solutions. Interested parties should note that the proposal submission deadline has been extended to November 15, 2024, and can contact Rebecca Harmon at rebecca.harmon@ati.org for further information.
    Contractor-Hosted Fully Integrated Records Facility (FIRF) IDIQ
    Active
    Health And Human Services, Department Of
    The U.S. Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is conducting market research for a Contractor-Hosted Fully Integrated Records Facility (FIRF) services under an Indefinite Delivery-Indefinite Quantity (IDIQ) contract. The objective is to identify potential small business sources capable of providing comprehensive services such as document processing, data entry, and record tracking, aimed at enhancing the management of records related to public health. This initiative is crucial for improving operational efficiency and ensuring compliance with federal regulations, ultimately supporting the FDA's mission to safeguard public health. Interested vendors must submit their responses, including a completed Vendor Feedback Form and comments on the draft Statement of Work, via email to Contract Specialist Noah Wills by 12:00 PM (Eastern) on November 19, 2024, with the anticipated contract period running from September 15, 2025, to September 14, 2030.